AL-3778

DRUG2 trials

Sponsors

Alios Biopharma Inc.

Conditions

Chronic Hepatitis BHepatitis BHepatitis B, ChronicViral Hepatitis B

Phase 1

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

TerminatedNCT03032536

Alios Biopharma Inc.Chronic Hepatitis B, Hepatitis B, Viral Hepatitis B

Start: 2017-01-31End: 2017-06-28Updated: 2017-10-16

Phase 2

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

WithdrawnNCT03125213

Alios Biopharma Inc.Hepatitis B, Chronic

Start: 2017-09-12End: 2019-02-15Updated: 2017-10-16